Molecular Partners AG (SWX:MOLN)
3.655
-0.245 (-6.28%)
Mar 9, 2026, 5:31 PM CET
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 145.86 million as of March 9, 2026. Its market cap has decreased by -12.10% in one year.
Market Cap
145.86M
Enterprise Value
42.87M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.66
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 145.86M, a decrease of -65.77%. That is a compound annual growth rate of -9.02%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioVersys AG | 149.71M |
| Xlife Sciences AG | 127.46M |
| Santhera Pharmaceuticals Holding AG | 213.08M |
| Newron Pharmaceuticals | 366.19M |
| Basilea Pharmaceutica AG | 639.16M |
| Idorsia | 887.82M |
| EvoNext Holdings | 6.98M |
| Addex Therapeutics | 5.83M |